E-LIB Suche - Ergebnisse für: Komura, Takahiro

1

Discovery of a Novel Sn(II)‐Based Oxide β‐SnMoO4 for Daylig..:

Hayashi, Hiroyuki ; Katayama, Shota ; Komura, Takahiro...
Advanced Science. 4 (2016) 1 - p. , 2016

Link: https://doi.org/10.1002/..

2

Zoledronic acid combined with androgen-deprivation therapy ..:

Nagao, Kazuhiro ; Matsuyama, Hideyasu ; Nozawa, Masahiro...
Asian Journal of Urology. 3 (2016) 1 - p. 33-38 , 2016

Link: https://doi.org/10.1016/..

3

Significance of baseline bone markers on disease progressio..:

Nozawa, Masahiro ; Hara, Isao ; Matsuyama, Hideyasu...
World Journal of Urology. 33 (2014) 9 - p. 1263-1268 , 2014

Link: https://doi.org/10.1007/..

4

Phase II trial of zoledronic acid combined with androgen-de..:

Nozawa, Masahiro ; Inagaki, Takeshi ; Nagao, Kazuhiro...
International Journal of Clinical Oncology. 19 (2013) 4 - p. 693-701 , 2013

Link: https://doi.org/10.1007/..

5

Effects of Etidronate Disodium on Crystallizations in Synth..:

Ebisuno, Shoichi ; Kohjimoto, Yasuo ; Nishikawa, Toru...
International Journal of Urology. 5 (1998) 6 - p. 582-587 , 1998

Link: https://doi.org/10.1111/..

6

Zoledronic acid combined with androgen-deprivation therapy ..:

Nagao, Kazuhiro ; Matsuyama, Hideyasu ; Nozawa, Masahiro...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5730815/. , 2016

Link: http://www.ncbi.nlm.nih...

7

Discovery of a Novel Sn(II)-Based Oxide β-SnMoO 4 for Dayli..:

Hayashi, Hiroyuki ; Katayama, Shota ; Komura, Takahiro...
10.1002/advs.201600246. , 2016

Link: http://hdl.handle.net/24..

8

Discovery of a Novel Sn(II)‐Based Oxide β‐SnMoO4 for Daylig..:

Hayashi, Hiroyuki ; Katayama, Shota ; Komura, Takahiro...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5238750/. , 2016

Link: http://www.ncbi.nlm.nih...

9

Zoledronic acid combined with androgen-deprivation therapy ..:

Kazuhiro Nagao ; Hideyasu Matsuyama ; Masahiro Nozawa...
http://www.sciencedirect.com/science/article/pii/S2214388215001149. , 2016

Link: https://doi.org/10.1016/..

10

Arterial oxygen pressure during veno-venous extracorporeal ..:

Nakamura, Tomoyuki ; Kuriyama, Naohide ; Hara, Yoshitaka...
Journal of Artificial Organs. , 2024

Link: https://doi.org/10.1007/..

11

Durable Response to Enfortumab Vedotin Compared to Re-chall..:

Uchimoto, Taizo ; Tsuchida, Shuya ; Komura, Kazumasa...
Targeted Oncology. 19 (2024) 3 - p. 401-410 , 2024

Link: https://doi.org/10.1007/..

12

Characterisation of colorectal cancer by hierarchical clust..:

Ito, Sunao ; Koshino, Akira ; Wang, Chengbo...
The Journal of Pathology: Clinical Research. 10 (2024) 4 - p. , 2024

Link: https://doi.org/10.1002/..

13

C-Reactive Protein-Albumin Ratio Predicts Objective Respons..:

Uchimoto, Taizo ; Matsuda, Takuya ; Komura, Kazumasa...
Targeted Oncology. , 2024

Link: https://doi.org/10.1007/..

14

Comparison of the efficacy of enfortumab vedotin between pa..:

Hirasawa, Yosuke ; Adachi, Takahiro ; Hashimoto, Takeshi...
Journal of Cancer Research and Clinical Oncology. 150 (2024) 4 - p. , 2024

Link: https://doi.org/10.1007/..

15

Prognostic Impact of Immune-Related Adverse Events as First..:

Nukaya, Takuhisa ; Takahara, Kiyoshi ; Yoshizawa, Atsuhiko...
Clinical Genitourinary Cancer. 22 (2024) 1 - p. 76-83 , 2024

Link: https://doi.org/10.1016/..